The purpose of this study is to show equal efficacy of both quetiapine and risperidone in subjects treated with study medication for up to 8 weeks.
Study Type
INTERVENTIONAL
Purpose
TREATMENT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Birmingham, Alabama, United States
Unnamed facility
Phoenix, Arizona, United States
Unnamed facility
Anaheim, California, United States
Unnamed facility
Cerritos, California, United States
Unnamed facility
Chula Vista, California, United States
Unnamed facility
Glendale, California, United States
Unnamed facility
Hawthorne, California, United States
Unnamed facility
Long Beach, California, United States
Unnamed facility
San Diego, California, United States
Unnamed facility
Santa Ana, California, United States
...and 54 more locations